| Amgen (AMGN) |
United States |
$143.489B |
16.53 |
| CSL (CSLLY) |
Australia |
$94.378B |
0.00 |
| Gilead Sciences (GILD) |
United States |
$79.679B |
9.87 |
| Vertex Pharmaceuticals (VRTX) |
United States |
$60.644B |
61.90 |
| Biogen (BIIB) |
United States |
$51.516B |
8.84 |
| Illumina (ILMN) |
United States |
$47.734B |
52.37 |
| Regeneron Pharmaceuticals (REGN) |
United States |
$42.374B |
18.56 |
| Alexion Pharmaceuticals (ALXN) |
United States |
$25.066B |
12.38 |
| Seattle Genetics (SGEN) |
United States |
$18.681B |
0.00 |
| SINO PHARMACEUT (SBMFF) |
Hong Kong, SAR China |
$18.631B |
0.00 |
| Incyte (INCY) |
United States |
$17.339B |
40.25 |
| BioMarin Pharmaceutical (BMRN) |
United States |
$15.856B |
0.00 |
| Genmab (GNMSF) |
Denmark |
$13.895B |
61.37 |
| Alnylam Pharmaceuticals (ALNY) |
United States |
$13.247B |
0.00 |
| Galapagos (GLPG) |
Belgium |
$12.482B |
32.16 |
| Exact Sciences (EXAS) |
United States |
$11.433B |
0.00 |
| Bio-Rad Laboratories (BIO.B) |
United States |
$11.238B |
53.94 |
| BeiGene (BGNE) |
Cayman Islands |
$10.404B |
0.00 |
| Sarepta Therapeutics (SRPT) |
United States |
$9.534B |
0.00 |
| Bio-Techne Corp (TECH) |
United States |
$8.408B |
56.28 |
| QIAGEN (QGEN) |
Netherlands |
$8.064B |
26.29 |
| Guardant Health (GH) |
United States |
$7.944B |
0.00 |
| BioNTech SE (BNTX) |
Germany |
$7.507B |
0.00 |
| Horizon Therapeutics Public (HZNP) |
Ireland |
$7.192B |
18.29 |
| Amarin (AMRN) |
Ireland |
$7.112B |
0.00 |
| Moderna (MRNA) |
United States |
$6.872B |
0.00 |
| ACADIA Pharmaceuticals (ACAD) |
United States |
$6.689B |
0.00 |
| Reata Pharmaceuticals (RETA) |
United States |
$6.400B |
0.00 |
| Exelixis (EXEL) |
United States |
$6.022B |
16.94 |
| ARGENX SE-ADR (ARGX) |
Netherlands |
$5.884B |
0.00 |
| Ascendis Pharma (ASND) |
Denmark |
$5.862B |
0.00 |
| Bluebird Bio (BLUE) |
United States |
$5.425B |
0.00 |
| Repligen (RGEN) |
United States |
$5.243B |
95.01 |
| China Biologic Products (CBPO) |
China |
$4.558B |
25.68 |
| MorphoSys AG (MOR) |
Germany |
$4.166B |
0.00 |
| Blueprint Medicines (BPMC) |
United States |
$3.990B |
0.00 |
| Mirati Therapeutics (MRTX) |
United States |
$3.827B |
0.00 |
| Immunomedics (IMMU) |
United States |
$3.675B |
0.00 |
| Adaptive Biotechnologies (ADPT) |
United States |
$3.508B |
0.00 |
| Intercept Pharmaceuticals (ICPT) |
United States |
$3.473B |
0.00 |
| Ultragenyx Pharmaceutical (RARE) |
United States |
$3.464B |
0.00 |
| MyoKardia (MYOK) |
United States |
$3.409B |
0.00 |
| NeoGenomics (NEO) |
United States |
$3.346B |
178.06 |
| CRISPR Therapeutics AG (CRSP) |
Switzerland |
$3.220B |
0.00 |
| Zai Lab (ZLAB) |
China |
$3.085B |
0.00 |
| Alkermes (ALKS) |
Ireland |
$3.031B |
0.00 |
| Momenta Pharmaceuticals (MNTA) |
United States |
$3.030B |
0.00 |
| Acceleron Pharma (XLRN) |
United States |
$2.980B |
0.00 |
| UniQure (QURE) |
Netherlands |
$2.946B |
0.00 |
| Genmab (GMAB) |
Denmark |
$2.929B |
6.03 |
| Halozyme Therapeutics (HALO) |
United States |
$2.926B |
0.00 |
| Emergent Biosolutions (EBS) |
United States |
$2.868B |
28.49 |
| Amicus Therapeutics (FOLD) |
United States |
$2.653B |
0.00 |
| Epizyme (EPZM) |
United States |
$2.434B |
0.00 |
| Arena Pharmaceuticals (ARNA) |
United States |
$2.339B |
5.44 |
| RA PHARMCTL INC (RARX) |
United States |
$2.214B |
0.00 |
| Denali Therapeutics (DNLI) |
United States |
$2.147B |
0.00 |
| Myriad Genetics (MYGN) |
United States |
$2.136B |
31.56 |
| Principia Biopharma (PRNB) |
United States |
$2.070B |
0.00 |
| Fate Therapeutics (FATE) |
United States |
$1.939B |
0.00 |
| Zymeworks (ZYME) |
Canada |
$1.935B |
0.00 |
| Insmed (INSM) |
United States |
$1.917B |
0.00 |
| REGENXBIO (RGNX) |
United States |
$1.774B |
0.00 |
| Arvinas (ARVN) |
United States |
$1.718B |
0.00 |
| Akcea Therapeutics (AKCA) |
United States |
$1.601B |
0.00 |
| Ligand Pharmaceuticals (LGND) |
United States |
$1.588B |
30.54 |
| Editas Medicine (EDIT) |
United States |
$1.572B |
0.00 |
| Alector (ALEC) |
United States |
$1.474B |
0.00 |
| Dicerna Pharmaceuticals (DRNA) |
United States |
$1.461B |
0.00 |
| Intra-Cellular Therapies (ITCI) |
United States |
$1.455B |
0.00 |
| Nabriva Therapeutics AG (NBRV) |
Ireland |
$1.390B |
0.00 |
| Orchard Therapeutics (ORTX) |
United Kingdom |
$1.376B |
0.00 |
| Coherus BioSciences (CHRS) |
United States |
$1.344B |
0.00 |
| Zealand Pharma (ZLDPF) |
Denmark |
$1.292B |
0.00 |
| Athenex (ATNX) |
United States |
$1.184B |
0.00 |
| DBV Technologies S.A (DBVT) |
France |
$1.157B |
0.00 |
| Zealand Pharma (ZEAL) |
Denmark |
$1.156B |
0.00 |
| Codexis (CDXS) |
United States |
$1.060B |
0.00 |
| Revance Therapeutics (RVNC) |
United States |
$1.013B |
0.00 |
| Sangamo Therapeutics (SGMO) |
United States |
$0.970B |
0.00 |
| PHARMA MAR SA (PHMMF) |
Spain |
$0.965B |
0.00 |
| Pharming Group (PHGUF) |
Netherlands |
$0.939B |
0.00 |
| Mesoblast (MESO) |
Australia |
$0.936B |
0.00 |
| BAVARIAN NORDIC (BVNRY) |
Denmark |
$0.902B |
0.00 |
| Heska (HSKA) |
United States |
$0.845B |
215.86 |
| ZIOPHARM Oncology Inc (ZIOP) |
United States |
$0.840B |
0.00 |
| Vanda Pharmaceuticals (VNDA) |
United States |
$0.806B |
6.78 |
| Vericel (VCEL) |
United States |
$0.781B |
291.17 |
| Cellectis S.A (CLLS) |
France |
$0.774B |
0.00 |
| GENFIT S.A (GNFT) |
France |
$0.773B |
0.00 |
| Adverum Biotechnologies (ADVM) |
United States |
$0.757B |
0.00 |
| Twist Bioscience (TWST) |
United States |
$0.756B |
0.00 |
| ANI Pharmaceuticals (ANIP) |
United States |
$0.741B |
12.63 |
| NantKwest (NK) |
United States |
$0.723B |
0.00 |
| Cytokineticsorporated (CYTK) |
United States |
$0.717B |
0.00 |
| Intellia Therapeutics (NTLA) |
United States |
$0.715B |
0.00 |
| Sorrento Therapeutics (SRNE) |
United States |
$0.715B |
0.00 |
| Basilea Pharmaceutica AG (BPMUF) |
Switzerland |
$0.713B |
0.00 |
| UROGEN PHARMA (URGN) |
United States |
$0.707B |
0.00 |
| Retrophin (RTRX) |
United States |
$0.695B |
0.00 |
| Cara Therapeutics (CARA) |
United States |
$0.693B |
0.00 |
| Anika Therapeutics (ANIK) |
United States |
$0.648B |
21.03 |
| AC Immune SA (ACIU) |
Switzerland |
$0.622B |
14.38 |
| Kadmon Holdings (KDMN) |
United States |
$0.589B |
0.00 |
| OXFORD BIOMEDCL (OXBDF) |
United Kingdom |
$0.578B |
0.00 |
| Prothena (PRTA) |
Ireland |
$0.569B |
0.00 |
| Precision BioSciences (DTIL) |
United States |
$0.542B |
0.00 |
| Agenus (AGEN) |
United States |
$0.541B |
0.00 |
| Clovis Oncology (CLVS) |
United States |
$0.540B |
0.00 |
| BioDelivery Sciences (BDSI) |
United States |
$0.522B |
0.00 |
| Aquinox Pharmaceuticals (NLTX) |
United States |
$0.513B |
0.00 |
| Dynavax Technologies (DVAX) |
United States |
$0.506B |
0.00 |
| Autolus Therapeutics (AUTL) |
United Kingdom |
$0.504B |
0.00 |
| Bellus Health (BLU) |
Canada |
$0.486B |
0.00 |
| Adaptimmune Therapeutics (ADAP) |
United Kingdom |
$0.473B |
0.00 |
| Arcus Biosciences (RCUS) |
United States |
$0.469B |
0.00 |
| Sinovac Biotech (SVA) |
China |
$0.460B |
0.00 |
| Xenon Pharmaceuticals (XENE) |
Canada |
$0.450B |
0.00 |
| AnaptysBio (ANAB) |
United States |
$0.431B |
0.00 |
| Lexicon Pharmaceuticals (LXRX) |
United States |
$0.429B |
2.97 |
| Gritstone Oncology (GRTS) |
United States |
$0.402B |
0.00 |
| AMAG Pharmaceuticals (AMAG) |
United States |
$0.401B |
0.00 |
| Merus (MRUS) |
Netherlands |
$0.397B |
0.00 |
| Mersana Therapeutics (MRSN) |
United States |
$0.385B |
0.00 |
| Kindred Biosciences (KIN) |
United States |
$0.385B |
0.00 |
| Puma Biotechnology (PBYI) |
United States |
$0.379B |
0.00 |
| PDL BioPharma (PDLI) |
United States |
$0.372B |
9.31 |
| Avid Bioservices (CDMO) |
United States |
$0.368B |
0.00 |
| Syros Pharmaceuticals (SYRS) |
United States |
$0.361B |
0.00 |
| Cue Biopharma (CUE) |
United States |
$0.354B |
0.00 |
| Stemline Therapeutics (STML) |
United States |
$0.352B |
0.00 |
| POXEL SA FRANCE (PXXLF) |
France |
$0.350B |
0.00 |
| CytomX Therapeutics (CTMX) |
United States |
$0.339B |
0.00 |
| Cellular Biomedicine (CBMG) |
United States |
$0.337B |
0.00 |
| Inovio Pharmaceuticals (INO) |
United States |
$0.329B |
0.00 |
| Albireo Pharma (ALBO) |
United States |
$0.317B |
0.00 |
| Compugen (CGEN) |
Israel |
$0.314B |
0.00 |
| MannKind (MNKD) |
United States |
$0.312B |
0.00 |
| Starpharma Holdings (SPHRY) |
Australia |
$0.303B |
0.00 |
| OSMOTICA PHARM (OSMT) |
United States |
$0.302B |
0.00 |
| VBI Vaccines (VBIV) |
United States |
$0.291B |
0.00 |
| IVERIC Bio (ISEE) |
United States |
$0.282B |
0.00 |
| Geron (GERN) |
United States |
$0.282B |
0.00 |
| Sutro Biopharma (STRO) |
United States |
$0.276B |
0.00 |
| WAVE Life Sciences (WVE) |
Singapore |
$0.270B |
0.00 |
| ADMA Biologics Inc (ADMA) |
United States |
$0.265B |
0.00 |
| Kamada (KMDA) |
Israel |
$0.263B |
7.67 |
| ChromaDex (CDXC) |
United States |
$0.260B |
0.00 |
| Prometic Life Sciences (LMNL) |
Canada |
$0.257B |
0.00 |
| Biofrontera AG (BFRA) |
Germany |
$0.254B |
0.00 |
| Syndax Pharmaceuticals (SNDX) |
United States |
$0.245B |
0.00 |
| Seres Therapeutics (MCRB) |
United States |
$0.240B |
0.00 |
| Affimed (AFMD) |
Germany |
$0.230B |
0.00 |
| Aeglea BioTherapeutics (AGLE) |
United States |
$0.230B |
0.00 |
| Cerecor (CERC) |
United States |
$0.222B |
0.00 |
| Theratechnologies (THTX) |
Canada |
$0.218B |
0.00 |
| XOMA (XOMA) |
United States |
$0.215B |
0.00 |
| Exicure (XCUR) |
United States |
$0.214B |
0.00 |
| Nymox Pharmaceutical (NYMX) |
Canada |
$0.214B |
0.00 |
| Athersys (ATHX) |
United States |
$0.199B |
0.00 |
| Bicycle Therapeutics (BCYC) |
United Kingdom |
$0.198B |
0.00 |
| Five Prime Therapeutics (FPRX) |
United States |
$0.193B |
0.00 |
| Arbutus Biopharma (ABUS) |
Canada |
$0.191B |
0.00 |
| Novavax (NVAX) |
United States |
$0.184B |
0.00 |
| EYEPOINT PHARMACEUTICALS, INC (EYPT) |
United States |
$0.184B |
0.00 |
| ARAVIVE, INC (ARAV) |
United States |
$0.184B |
0.00 |
| Fortress Biotech (FBIO) |
United States |
$0.183B |
0.00 |
| Pieris Pharmaceuticals (PIRS) |
United States |
$0.182B |
0.00 |
| Alcobra (ARCT) |
United States |
$0.180B |
0.00 |
| Windtree Therapeutics (WINT) |
United States |
$0.172B |
0.00 |
| TELA Bio (TELA) |
United States |
$0.170B |
0.00 |
| Spero Therapeutics (SPRO) |
United States |
$0.170B |
0.00 |
| PHASEBIO PHARMA (PHAS) |
United States |
$0.168B |
0.00 |
| Menlo Therapeutics (MNLO) |
United States |
$0.163B |
0.00 |
| Selecta Biosciences (SELB) |
United States |
$0.160B |
0.00 |
| Dyadic (DYAI) |
United States |
$0.159B |
0.00 |
| Aptinyx (APTX) |
United States |
$0.154B |
0.00 |
| Applied Genetic Technologies (AGTC) |
United States |
$0.149B |
0.00 |
| Strongbridge Biopharma (SBBP) |
United States |
$0.149B |
3.97 |
| Verastem (VSTM) |
United States |
$0.141B |
0.00 |
| Newron Pharmaceuticals SpA (NWPHF) |
Italy |
$0.134B |
0.00 |
| Northwest Biotherapeutics (NWBO) |
United States |
$0.130B |
0.00 |
| Abeona Therapeutics (ABEO) |
United States |
$0.130B |
0.00 |
| Arsanis (XFOR) |
United States |
$0.129B |
0.00 |
| VTv Therapeutics (VTVT) |
United States |
$0.128B |
0.00 |
| Clearside Biomedical (CLSD) |
United States |
$0.126B |
0.00 |
| Enzo Biochem (ENZ) |
United States |
$0.125B |
0.00 |
| Paratek Pharmaceuticals (PRTK) |
United States |
$0.121B |
0.00 |
| Liquidia Technologies (LQDA) |
United States |
$0.120B |
0.00 |
| Celyad SA (CYAD) |
Belgium |
$0.118B |
0.00 |
| Aduro Biotech (ADRO) |
United States |
$0.113B |
0.00 |
| Antibe Therapeutics (ATBPF) |
Canada |
$0.112B |
0.00 |
| Happiness Biotech Group (HAPP) |
China |
$0.110B |
0.00 |
| OvaScience (MLND) |
United States |
$0.106B |
0.00 |
| AVEO Pharmaceuticals (AVEO) |
United States |
$0.102B |
0.00 |
| SESEN BIO, INC (SESN) |
United States |
$0.102B |
0.00 |
| Proteostasis Therapeutics (PTI) |
United States |
$0.100B |
0.00 |
| Acorda Therapeutics (ACOR) |
United States |
$0.099B |
0.00 |
| Synlogic (SYBX) |
United States |
$0.096B |
0.00 |
| AIT Therapeutics (XAIR) |
United States |
$0.093B |
0.00 |
| Emmaus Life Sciences (EMMA) |
United States |
$0.090B |
0.00 |
| Catalyst Biosciences (CBIO) |
United States |
$0.089B |
0.00 |
| Orgenesis (ORGS) |
United States |
$0.087B |
5.63 |
| Adocia (ADOCY) |
France |
$0.086B |
0.00 |
| Prima BioMed (IMMP) |
Australia |
$0.084B |
0.00 |
| Catabasis Pharmaceuticals (CATB) |
United States |
$0.083B |
0.00 |
| Trevena (TRVN) |
United States |
$0.081B |
0.00 |
| NewLink Genetics (NLNK) |
United States |
$0.076B |
0.00 |
| Vaccinex (VCNX) |
United States |
$0.076B |
0.00 |
| ANIXA BIOSCIENCES INC (ANIX) |
United States |
$0.072B |
0.00 |
| Checkpoint Therapeutics (CKPT) |
United States |
$0.069B |
0.00 |
| Aridis Pharmaceuticals (ARDS) |
United States |
$0.066B |
0.00 |
| Pluristem Therapeutics (PSTI) |
Israel |
$0.064B |
0.00 |
| Idera Pharmaceuticals (IDRA) |
United States |
$0.062B |
0.00 |
| Sunesis Pharmaceuticals (SNSS) |
United States |
$0.062B |
0.00 |
| Organovo Holdings (ONVO) |
United States |
$0.060B |
0.00 |
| Curis (CRIS) |
United States |
$0.057B |
0.00 |
| DiaMedica Therapeutics (DMAC) |
United States |
$0.053B |
0.00 |
| Vascular Biogenics (VBLT) |
Israel |
$0.051B |
0.00 |
| AquaBounty Technologies (AQB) |
United States |
$0.049B |
0.00 |
| CollPlant Holdings (CLGN) |
Israel |
$0.044B |
0.00 |
| Evogene (EVGN) |
Israel |
$0.044B |
0.00 |
| Soligenix (SNGX) |
United States |
$0.043B |
0.00 |
| Celldex Therapeutics (CLDX) |
United States |
$0.040B |
0.00 |
| Celsion (CLSN) |
United States |
$0.037B |
0.00 |
| BioCardia (BCDA) |
United States |
$0.035B |
0.00 |
| Alimera Sciences (ALIM) |
United States |
$0.035B |
0.00 |
| Pulmatrix (PULM) |
United States |
$0.033B |
0.00 |
| Entera Bio (ENTX) |
Israel |
$0.033B |
0.00 |
| Bionano Genomics (BNGO) |
United States |
$0.032B |
0.00 |
| VistaGen Therapeutics (VTGN) |
United States |
$0.031B |
0.00 |
| Aptevo Therapeutics (APVO) |
United States |
$0.031B |
0.00 |
| Oncobiologics (OTLK) |
United States |
$0.029B |
0.00 |
| Unum Therapeutics (UMRX) |
United States |
$0.029B |
0.00 |
| VIVUS (VVUS) |
United States |
$0.029B |
0.00 |
| Novogen (KZIA) |
Australia |
$0.029B |
0.00 |
| Stellar Biotechnologies (EDSA) |
Canada |
$0.027B |
0.00 |
| Aerpio Pharmaceuticals (ARPO) |
United States |
$0.025B |
0.00 |
| AEterna Zentaris (AEZS) |
United States |
$0.022B |
0.00 |
| Signal Genetics (MGEN) |
United States |
$0.021B |
0.00 |
| Advaxis (ADXS) |
United States |
$0.021B |
0.00 |
| Titan Pharmaceuticals (TTNP) |
United States |
$0.019B |
0.00 |
| Genetic Technologies (GENE) |
Australia |
$0.017B |
0.00 |
| Aytu Bioscience (AYTU) |
United States |
$0.017B |
0.00 |
| TOCAGEN INC (TOCA) |
United States |
$0.014B |
0.00 |
| Cyclacel Pharmaceuticals (CYCC) |
United States |
$0.014B |
0.00 |
| Cesca Therapeutics (THMO) |
United States |
$0.013B |
0.00 |
| MYOS RENS Technology (MYOS) |
United States |
$0.013B |
0.00 |
| IMMURON (IMRN) |
Australia |
$0.013B |
0.00 |
| TRACON Pharmaceuticals (TCON) |
United States |
$0.012B |
0.00 |
| Cleveland BioLabs (CBLI) |
United States |
$0.012B |
0.00 |
| Prana Biotechnology (ATHE) |
Australia |
$0.011B |
0.00 |
| TrovaGene (TROV) |
United States |
$0.011B |
0.00 |
| Benitec Biopharma (BNTC) |
Australia |
$0.006B |
0.00 |
| Neuralstem (SNCA) |
United States |
$0.006B |
0.00 |
